The question about studies on FTO and women ('FTO Frauen') cannot be directly answered from the provided context, as no specific studies or data on this topic are included. In general, the FTO gene (Fat Mass and Obesity-Associated) is one of the most robustly replicated risk genes for obesity and elevated BMI in GWAS studies. Risk variants (e.g., rs9939609) are associated with increased appetite, reduced satiety, and higher caloric intake – independent of sex. However, some population-based analyses suggest the effect may be slightly stronger in women, possibly due to hormonal interactions (e.g., estrogen). The evidence for this is moderate and based on observational studies, not randomized controlled trials. Importantly, genetic influence is only one factor; lifestyle, diet, and exercise significantly modify risk. A DNA test alone does not predict individual weight development. Clinical relevance for individual women remains limited until personalized intervention studies are available. Evidence grade: human-moderate (GWAS).
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-447b2ff55a33beaa3b10a58f